Bausch Health Companies Inc
TSX:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
TSX:BHC
Watchlist
Price: 9.53 CAD -1.35% Market Closed
Market Cap: 3.5B CAD

Wall Street
Price Targets

BHC Price Targets Summary
Bausch Health Companies Inc

Wall Street analysts forecast BHC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BHC is 10.2 CAD with a low forecast of 10.1 CAD and a high forecast of 10.5 CAD.

Lowest
Price Target
10.1 CAD
6% Upside
Average
Price Target
10.2 CAD
7% Upside
Highest
Price Target
10.5 CAD
10% Upside
Bausch Health Companies Inc Competitors:
Price Targets
INDOCO
Indoco Remedies Ltd
15% Upside
600993
Mayinglong Pharmaceutical Group Co Ltd
34% Upside
AJANTPHARM
Ajanta Pharma Ltd
16% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
32% Upside
000520
Samil Pharmaceutical Co Ltd
31% Upside
COLL
Collegium Pharmaceutical Inc
2% Downside
LAURUSLABS
Laurus Labs Ltd
11% Downside
NEU
Neuren Pharmaceuticals Ltd
34% Upside

Revenue
Forecast

Revenue Estimate
Bausch Health Companies Inc

For the last 13 years the compound annual growth rate for Bausch Health Companies Inc's revenue is 11%. The projected CAGR for the next 4 years is 0%.

11%
Past Growth
0%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bausch Health Companies Inc

For the last 13 years the compound annual growth rate for Bausch Health Companies Inc's operating income is 10%. The projected CAGR for the next 4 years is 11%.

10%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-57%
Average Miss

Net Income
Forecast

Net Income Estimate
Bausch Health Companies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-72%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BHC's stock price target?
Price Target
10.2 CAD

According to Wall Street analysts, the average 1-year price target for BHC is 10.2 CAD with a low forecast of 10.1 CAD and a high forecast of 10.5 CAD.

What is Bausch Health Companies Inc's Revenue forecast?
Projected CAGR
0%

For the last 13 years the compound annual growth rate for Bausch Health Companies Inc's revenue is 11%. The projected CAGR for the next 4 years is 0%.

What is Bausch Health Companies Inc's Operating Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Bausch Health Companies Inc's operating income is 10%. The projected CAGR for the next 4 years is 11%.

Back to Top